What Part of the Body Should You Inject Ozempic for Effective Weight Loss?

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist, is administered as a subcutaneous injection—meaning it goes into the layer of fatty tissue beneath the skin. Proper injection site selection is crucial for consistent drug absorption and optimal weight loss outcomes. PlexusDx compounded semaglutide injections start at $149/month and come with detailed guidance on administration technique from licensed pharmacies.

Approved Semaglutide Injection Locations

The abdomen, thigh, and upper arm are the three FDA-recommended injection sites for semaglutide and other GLP-1 medications. The abdomen offers the largest surface area and most consistent absorption, making it the preferred starting location for many patients. This area includes the skin around your belly button, excluding a 2-inch radius directly around the navel itself.

The thigh provides another reliable injection site with good blood flow and accessibility. Either the front or outer side of the thigh works effectively, and the thigh offers practical benefits since you can self-inject while sitting. The upper arm, specifically the back of the upper arm, is the third approved location and works best when a partner assists with injection or when using an injection pen device.

Why Rotation Between Sites Matters

Rotating your injection sites prevents lipohypertrophy—a thickening of fatty tissue that occurs when injections happen repeatedly in the same spot. This condition can reduce medication absorption and lead to inconsistent weight loss results over time. Healthcare providers recommend using a different location each week to distribute injections evenly across approved areas.

Systematic rotation also minimizes localized bruising, redness, and skin irritation that some patients experience. A simple tracking method involves designating each approved site to a different week: week one in the abdomen, week two in the thigh, week three in the upper arm, then repeating the cycle. This approach ensures adequate healing time between injections at each location while maintaining steady medication delivery.

Injection Technique for Maximum Absorption

Successful semaglutide injection requires inserting the needle at a 45-to-90-degree angle into the subcutaneous layer—the fatty tissue between skin and muscle. Pinching the skin gently creates a small fold that makes injection easier and ensures the medication reaches the correct tissue depth. Depth matters because injecting too shallow or too deep affects how quickly the body absorbs the medication.

Before injecting, ensure the injection site is clean and dry; alcohol wipes work well for sanitizing. Allow the alcohol to air dry for 15-30 seconds before injecting to prevent stinging and ensure sterility. After injection, you may apply light pressure to the site with a clean gauze pad if needed, though most people don't experience bleeding. Never reuse needles, and dispose of used needles in a designated sharps container.

How PlexusDx Supports Proper Injection Administration

PlexusDx compounded semaglutide injections are formulated by licensed 503A compounding pharmacies and arrive with clear instructions for safe self-administration. Each patient receives detailed guidance on selecting appropriate injection sites, rotating locations, and recognizing normal versus concerning reactions. PlexusDx also provides access to clinical support to answer questions about injection technique throughout your weight loss journey.

For patients seeking deeper personalization, the Precision Peptide Genetic Test ($99 add-on after first month) identifies how your genes influence GLP-1 receptor sensitivity and peptide metabolism. Understanding your genetic predisposition to medication response helps PlexusDx optimize your treatment plan and injection protocol. Compounded semaglutide injections from PlexusDx work with all 50 states, require no insurance, and are HSA/FSA eligible—making personalized weight loss accessible and affordable.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week?

No. Repeated injections in the same location cause lipohypertrophy, a thickening of fatty tissue that reduces medication absorption and weight loss consistency. PlexusDx recommends rotating between the abdomen, thigh, and upper arm weekly to maintain steady drug delivery and minimize skin reactions.

Which injection site absorbs semaglutide fastest?

The abdomen typically provides the most consistent absorption due to its larger surface area and stable blood flow. However, all three approved sites—abdomen, thigh, and upper arm—deliver reliable results when proper injection technique is used. Site selection can be based on personal comfort and accessibility.

What is PlexusDx compounded semaglutide and how much does it cost?

PlexusDx compounded semaglutide injections are formulated by licensed 503A compounding pharmacies and cost from $149/month flat—your dose may need to go up, but your price won't. PlexusDx serves all 50 states with no insurance needed and offers HSA/FSA eligibility for added affordability.

What happens if I inject semaglutide into muscle instead of fat?

Injecting into muscle (intramuscular) rather than the subcutaneous fat layer can cause faster absorption, unpredictable drug levels, and increased side effects like nausea or pain. Always aim for the 45-to-90-degree angle into pinched skin to ensure medication enters the fatty tissue layer where it's designed to work.

Can genetic testing help me use semaglutide more effectively?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes key variants like GLP1R rs6923761 and GIPR rs1800437 to reveal how your genes influence semaglutide response and peptide metabolism. This insight helps PlexusDx personalize your injection protocol and medication choice for better weight loss outcomes.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.